Compare PINS & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PINS | ZBH |
|---|---|---|
| Founded | 2008 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7B | 18.7B |
| IPO Year | 2019 | N/A |
| Metric | PINS | ZBH |
|---|---|---|
| Price | $26.11 | $89.41 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 30 | 20 |
| Target Price | $38.86 | ★ $107.00 |
| AVG Volume (30 Days) | ★ 17.5M | 2.3M |
| Earning Date | 02-05-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 1.08% |
| EPS Growth | ★ 824.42 | N/A |
| EPS | 2.88 | ★ 4.03 |
| Revenue | $4,056,550,000.00 | ★ $8,010,900,000.00 |
| Revenue This Year | $18.43 | $7.99 |
| Revenue Next Year | $15.54 | $5.20 |
| P/E Ratio | ★ $9.05 | $22.10 |
| Revenue Growth | ★ 16.79 | 5.47 |
| 52 Week Low | $23.68 | $85.33 |
| 52 Week High | $40.90 | $114.44 |
| Indicator | PINS | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 42.78 | 37.86 |
| Support Level | $25.45 | $90.46 |
| Resistance Level | $26.75 | $92.82 |
| Average True Range (ATR) | 0.78 | 2.09 |
| MACD | 0.12 | -0.24 |
| Stochastic Oscillator | 28.91 | 10.05 |
Pinterest is a social media platform with a focus on product and idea discovery. Pinterest users, or pinners, can leverage the platform as they go about gathering ideas on topics such as home improvement, fashion, cooking, and travel. The company has more than 500 million monthly active users, two thirds of whom are female. Pinterest generates revenue by selling digital ads on its platform. While the platform's user base spans the globe, the vast majority of its revenue stems from ads shown to North American users.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.